Rare refractory Kawasaki disease in an adolescent boy with cardiac and diffuse coronary artery involvement
Rima Šileikienė1, Jolanta Kudzytė, Antanas Jankauskas
1Department of Children Diseases, Medical Academy, Lithuanian University of Health Scien-ces, Eivenių 2, 50161 Kaunas, Lithuania. rima.sileikiene@kaunoklinikos.lt.
Insights
Kawasaki disease, a rare childhood vasculitis, can affect adolescents and adults, leading to severe heart damage. This case highlights challenges in treating resistant forms, emphasizing timely diagnosis and management for better outcomes.
Area of Science:
- Pediatric Rheumatology
- Cardiovascular Medicine
- Immunology
Background:
- Kawasaki disease is an acute, multisystemic vasculitis primarily affecting young children.
- While rare, it can occur in adolescents and adults, potentially leading to delayed diagnosis and coronary artery aneurysms.
- Refractory cases, resistant to standard treatments like intravenous immunoglobulin and aspirin, pose significant management challenges.
Observation:
- This report details a case of Kawasaki disease in an adolescent boy.
- The patient exhibited resistance to standard intravenous immunoglobulin and aspirin therapy.
- Severe cardiovascular damage was observed in the affected adolescent.
Findings:
- The case underscores the potential for severe cardiovascular complications in adolescents with Kawasaki disease.
- Treatment resistance in Kawasaki disease necessitates exploring alternative therapeutic strategies.
- Early recognition and aggressive management are crucial, even in atypical presentations.
Implications:
- This case highlights the need for increased awareness of Kawasaki disease in older age groups.
- Management protocols for refractory Kawasaki disease require further investigation and refinement.
- Prompt and effective treatment is vital to prevent long-term cardiovascular sequelae in affected individuals.
Abstract:
Kawasaki disease is an acute multisystemic vasculitis occurring predominantly in infants and young children and rarely in adolescents and adults. At elderly age, Kawasaki disease may remain unrecognized with a subsequent delay in appropriate therapy and an increased risk of coronary artery aneurysms. We report a case of intravenous immunoglobulin- and aspirin-resistant Kawasaki disease and severe cardiovascular damage in an adolescent boy. The article discusses major issues associated with the management of refractory Kawasaki disease.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Mitral Stenosis II: Clinical features and Diagnostic Tests


